Related Experiment Videos
Retroperitoneal sarcomas. An analysis of 32 cases
T E Bolin1, S G Bolin, J Wetterfors
1Department of Surgery, University of Linköping, Sweden.
Acta Chirurgica Scandinavica
|November 1, 1988
Summary
Retroperitoneal sarcoma treatment in 32 patients showed that while primary radical resection offered a 46% 5-year survival, aggressive surgical management of recurrences is key. Early detection and intervention improve outcomes for this rare cancer.
Area of Science:
- Oncology
- Surgical Oncology
- Medical Imaging
Background:
- Retroperitoneal sarcomas are rare malignancies.
- Pain and palpable masses are common initial presentations.
- Surgical resection is the primary treatment modality.
Purpose of the Study:
- To evaluate the outcomes of retroperitoneal sarcoma treatment.
- To assess the impact of surgical approach on survival rates.
- To explore the role of aggressive management in recurrent disease.
Main Methods:
- Retrospective analysis of 32 patients treated between 1970-1986.
- Detailed review of surgical interventions, including primary and repeat resections.
- Assessment of postoperative mortality and survival rates.
- Utilization of computed tomographic (CT) scanning for monitoring.
Main Results:
- Primary radical resection was achieved in 16 patients.
- Tumor recurrence occurred in 14 patients, with a median time to recurrence of 3-33 months.
- 57 tumor resections were performed in 23 patients.
- Postoperative mortality was 3.5%.
- Cumulative 5-year survival was 28%, increasing to 46% with radical primary resection.
Conclusions:
- Aggressive surgical management, including repeat resections for recurrent retroperitoneal sarcoma, is feasible and impacts survival.
- Periodic CT scanning aids in early detection of recurrence.
- An aggressive surgical approach to recurrent tumors can enhance prognosis.